Archived Shared Care Guidelines

The Shared care guidelines below have been archived, and are available for reference only. 

CCGs are not the responsible commissioners for these treatments; these services fall within the specialised services commissioned by NHS England.  Guidance should be provided to GPs by specialist services if requests are made to share care.

North and East Devon

Endocrine system
Lanreotide and Octreotide for acromegaly (ARCHIVED 26/05/2017) Somatropin - (growth hormone) use in children (ARCHIVED 26/05/2017)

Malignant disease and immunosuppression

Ciclosporin - renal transplantation (ARCHIVED 26/05/2017) Sirolimus - renal transplantation (ARCHIVED 26/05/2017) Tacrolimus - renal transplantation (ARCHIVED 26/05/2017) Lanreotide and Octreotide for the treatment of gastropancreatic tumours in adults (ARCHIVED 26/05/2017) Mycophenolate - organ transplant patients (ARCHIVED 26/05/2017)

Western Devon

Malignant disease and immunosuppression
Ciclosporin - solid organ transplants (ARCHIVED 26/05/2017) Sirolimus - prophylaxis of acute rejection in renal transplant recipients (ARCHIVED 26/05/2017) Somatostatin analogues for the treatment of acromegaly in adults (ARCHIVED 26/05/2017) Somatostatin analogues for the treatment of gastrointestinal neuroendocrine tumours (ARCHIVED 26/05/2017) Tacrolimus for the treatment of resistant rejection in transplant recipients (ARCHIVED 26/05/2017) Mycophenolate Mofetil - prophylaxis of acute rejection in renal and cardiac transplant recipients (ARCHIVED 12/01/2017) Mycophenolic acid - prophylaxis of acute rejection in renal transplant recipients (ARCHIVED 12/01/2017)

Rate this page